The Efficacy and Safety of Chidamide, Anti-PD-1 Antibody in Combination With Pegaspargase Versus DDGP in the Treatment of Newly Diagnosed, Stage III to IV Extranodal Natural Killer/T-Cell Lymphoma

Conditions: Extranodal Natural Killer T Cell Lymphoma Interventions: Drug: chidamide, anti-PD1 antibody, and pegaspargase; Drug: DDGP Sponsors: Ruijin Hospital Not yet recruiting
Source: - Category: Research Source Type: clinical trials